Skip to main content
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems
  • Log in
  • My alerts
  • My Cart

Main menu

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
  • ASM
    • Antimicrobial Agents and Chemotherapy
    • Applied and Environmental Microbiology
    • Clinical Microbiology Reviews
    • Clinical and Vaccine Immunology
    • EcoSal Plus
    • Eukaryotic Cell
    • Infection and Immunity
    • Journal of Bacteriology
    • Journal of Clinical Microbiology
    • Journal of Microbiology & Biology Education
    • Journal of Virology
    • mBio
    • Microbiology and Molecular Biology Reviews
    • Microbiology Resource Announcements
    • Microbiology Spectrum
    • Molecular and Cellular Biology
    • mSphere
    • mSystems

User menu

  • Log in
  • My alerts
  • My Cart

Search

  • Advanced search
Journal of Clinical Microbiology
publisher-logosite-logo

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Accepted Manuscripts
    • Archive
    • Minireviews
  • For Authors
    • Submit a Manuscript
    • Scope
    • Editorial Policy
    • Submission, Review, & Publication Processes
    • Organization and Format
    • Errata, Author Corrections, Retractions
    • Illustrations and Tables
    • Nomenclature
    • Abbreviations and Conventions
    • Publication Fees
    • Ethics Resources and Policies
  • About the Journal
    • About JCM
    • Editor in Chief
    • Editorial Board
    • For Reviewers
    • For the Media
    • For Librarians
    • For Advertisers
    • Alerts
    • RSS
    • FAQ
  • Subscribe
    • Members
    • Institutions
Immunoassays

Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae

David W. Wareham, Rishita Shah, Jonathan W. Betts, Lynette M. Phee, Muhd Haziq F. Abdul Momin
K. C. Carroll, Editor
David W. Wareham
Antimicrobial Research Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomDivision of Infection, Barts Health NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Rishita Shah
Antimicrobial Research Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan W. Betts
Antimicrobial Research Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lynette M. Phee
Antimicrobial Research Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United KingdomDivision of Infection, Barts Health NHS Trust, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Muhd Haziq F. Abdul Momin
Antimicrobial Research Group, Blizard Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
K. C. Carroll
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
DOI: 10.1128/JCM.02900-15
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

ABSTRACT

We evaluated an immunochromatographic lateral flow assay to detect OXA-48-like carbapenemases (OXA-48 K-SeT) in Enterobacteriaceae (n = 82). One hundred percent sensitivity and specificity were observed using bacteria recovered from both solid medium and spiked blood culture bottles, and the results were obtained in <10 min.

TEXT

The identification, treatment, and control of multidrug-resistant (MDR) bacterial infections are global health priorities. Enterobacteriaceae with plasmids carrying genes encoding class A (Klebsiella pneumoniae carbapenemases [KPC]), B (IMP, VIM, and NDM), and D (OXA) carbapenemases (carbapenemase-producing Enterobacteriaceae [CPE]) are one of the most important groups of pathogens due to the burden of disease, lack of any new treatments, and potential for dissemination (1). Rapid and effective diagnostics therefore underpin any strategy aimed at tackling the problem of CPE. Considerable effort has been made to develop novel assays using both genotypic and phenotypic approaches. These approaches include the genetic detection of resistance gene profiles (PCR, loop-mediated isothermal amplification [LAMP], microarrays, and genome sequencing) (2), selective culture medium (chromogenic or supplemented) (3), combination disk testing (4), and direct or indirect detection of carbapenem-hydrolyzing enzymes (matrix-assisted laser desorption ionization–time of flight mass spectrometry [MALDI-TOF MS], acidometric Carba NP, and Blue-Carba) (5–7). These methods require varied levels of technical skill, investment into equipment, and quality assurance optimization. Strains producing OXA-48-like carbapenem-hydrolyzing class D enzymes (CHDL) have proven to be particularly difficult to detect in clinical laboratories. This is due in part to relatively low MICs, conflicting interpretive rules associated with automated systems (8), and a lack of suitable inhibitor compounds for use in confirmatory tests. A novel means of detecting OXA-48-like enzymes using an antibody-mediated approach was recently developed (9). The OXA-48 K-SeT assay relies on the immunological capture of two epitopes specific to the OXA-48 enzyme using colloidal gold nanoparticles bound to a nitrocellulose membrane within a lateral flow device. Capture and detection antibodies were designed to bind all current CHDL OXA-48-like variants (OXA-48, -181, -204, -232, and -244).

In this study, we assessed the performance of the Coris OXA-48 K-SeT assay for detecting OXA-48-like-mediated carbapenem resistance in a large collection of carbapenem-resistant Enterobacteriaceae and also determined whether it could provide robust results when working directly with organisms recovered from blood culture bottles.

Eighty-two enterobacterial isolates were used in the evaluation. Seventy-eight were clinical isolates (K. pneumoniae, n = 60; Escherichia coli, n = 11; Enterobacter cloacae, n = 6; Enterobacter aerogenes, n = 1) with resistance to one or more carbapenems (ertapenem, imipenem, and/or meropenem) along with a susceptible type strain as a representative control for each bacterial species (K. pneumoniae NCTC 9633, E. coli NCTC 12241, E. cloacae 13380, and E. aerogenes NCTC 9375). Resistance or reduced susceptibility to carbapenems in clinical isolates was identified by disk diffusion and/or Etest (bioMérieux, Marcy L'Etoile, France) and confirmed by broth microtiter dilution (ertapenem MIC, ≥1 μg/ml), according to Clinical and Laboratory Standards Institute (CLSI) methodology. Multiplex PCRs were used to detect the presence of genes encoding class A, B, C, and D β-lactamases (10). PCR detection and Sanger sequencing of entire blaOXA-48 alleles were undertaken and used as the standard for all isolates designated OXA-48-like-positive strains (3, 11). OXA-48 K-SeT assay kits (Coris BioConcept, Gembloux, Belgium) were obtained commercially through BioConnections (Knypersley, United Kingdom) at the catalogue price in August 2015 (£5/$7.6 per cassette).

Isolates were grown and maintained on Mueller-Hinton II cation-adjusted agar plates (Sigma-Aldrich, Gillingham, United Kingdom). The detection of CHDL-producing isolates from solid medium was undertaken, according to the manufacturer's instructions. Briefly, a single colony was resuspended in 10 drops of LY-A buffer (Tris-HCl, NaN3 [pH 7.5]), and 3 drops of the homogenized solution was then applied to the sample well. The tests were read by eye within 15 min (Fig. 1). The lower limit of detection (in CFU per milliliter) of the OXA-48 K-SeT device was determined using K. pneumoniae NCTC 9633 and KP41 (blaOXA-48) grown in Trypticase soy broth (TSB) (Sigma). Cells from 1 ml of overnight cultures were harvested by centrifugation, resuspended in phosphate-buffered saline (PBS), plated in serial dilutions (10−1 to 10−9) onto MH agar, and viable counts (in CFU per milliliter) were recorded after 18 h of incubation. Ten drops of LY-A buffer were added to the cells pelleted from each dilution and used to inoculate OXA-48 K-SeT assay cassettes, as described above.

FIG 1
  • Open in new tab
  • Download powerpoint
FIG 1

Detection of OXA-48-producing K. pneumoniae using OXA-48 K-SeT assay cassettes. The device was inoculated with 2 × 106 CFU/ml of OXA-48-producing KP41 and read after 5 min.

The ability of the OXA-48 K-SeT system to directly detect OXA-48-producing isolates recovered using commercial microbial blood culture medium was performed using the BacT/Alert system (bioMérieux, Durham, NC). Aerobic FA Plus 30-ml bottles were supplemented with 10 ml of heparinized horse blood (Oxoid, Basingstoke, United Kingdom) before inoculation with 102 CFU of each of the test organisms. The bottles were incubated at 37°C for up to 18 h before 0.1-ml aliquots were harvested, lysed, and analyzed directly without further dilution. Adequate growth of each isolate under simulated blood culture conditions was confirmed by subculture on MH II agar.

Molecular analysis of the isolates used in the analysis confirmed that 53 isolates produced an OXA-48-like carbapenemase, including 2 K. pneumoniae isolates with the OXA-181 and OXA-232 variants. Twenty-five isolates were carbapenem resistant due to the production of either KPC, VIM, or NDM (n = 13) β-lactamases or had hyper-ampC and/or permeability lesions. The OXA-48 K-SeT assay gave a positive result for all 53 OXA-48-producing strains and was negative for all of the other isolates tested, including 5 isolates that produced OXA-1. A correlation of the viable colony counts with the OXA-48 K-SeT assay results obtained with K. pneumoniae NCTC 9633 and KP41 assessed the lower limit of detection of the assay to be 2.41 × 106 CFU/ml. The results were identical whether the cassettes were inoculated with lysates prepared from MH II plates or from BacT/Alert blood culture bottles. In this evaluation, complete agreement between the molecular and OXA-48 K-SeT assay results was demonstrated (Table 1), and the sensitivity and specificity of the assay for detecting OXA-48-producing isolates were both calculated to be 100% (95% confidence interval, 91.9 to 100% and 84.2 to 100%, respectively). Positive and negative results were clearly differentiated within 10 min. Furthermore, the reads were not obscured by the presence of red cells when using lysates from blood culture sets.

View this table:
  • View inline
  • View popup
TABLE 1

Detection of OXA-48 production in carbapenem-resistant Enterobacteriaceae using OXA-48 K-SeT cassettes

The OXA-48 K-SeT assay required minimal hands-on analytical time and no investment in any special equipment outside that available in a routine microbiology laboratory. The assay was highly sensitive and specific and was able to either rule in or rule out the presence of an OXA-48-producing strain within minutes. With a limit of detection of 106 CFU/ml, it might also be useful for the direct detection of OXA-48-producing strains in urinary samples or other biological fluids. Although we did not undertake a formal cost/benefit analysis, this assay has clear potential for development as a simple rapid local point-of-care test able to identify and guide the treatment and control of carbapenem-resistant infections due to OXA-48-producing Enterobacteriaceae.

ACKNOWLEDGMENTS

No specific funding was used to undertake this study, as it was performed as part of our routine activities.

We declare no conflicts of interest and have no association with Coris BioConcept.

FOOTNOTES

    • Received 29 October 2015.
    • Returned for modification 15 November 2015.
    • Accepted 18 November 2015.
    • Accepted manuscript posted online 25 November 2015.
  • Copyright © 2016, American Society for Microbiology. All Rights Reserved.

REFERENCES

  1. 1.↵
    1. Doi Y,
    2. Paterson DL
    . 2015. Carbapenemase-producing Enterobacteriaceae. Semin Respir Crit Care Med 36:74–84. doi:10.1055/s-0035-1544208.
    OpenUrlCrossRefPubMed
  2. 2.↵
    1. Osei Sekyere J,
    2. Govinden U,
    3. Essack SY
    . 2015 Review of established and innovative detection methods for carbapenemase-producing Gram-negative bacteria. J Appl Microbiol 119:1219–1233. doi:10.1111/jam.12918.
    OpenUrlCrossRef
  3. 3.↵
    1. Hornsey M,
    2. Phee L,
    3. Woodford N,
    4. Turton J,
    5. Meunier D,
    6. Thomas C,
    7. Wareham DW
    . 2013. Evaluation of three selective chromogenic media, CHROMagar ESBL, CHROMagar CTX-M and CHROMagar KPC, for the detection of Klebsiella pneumoniae producing OXA-48 carbapenemase. 66:348–350. doi:10.1136/jclinpath-2012-201234.
    OpenUrlAbstract/FREE Full Text
  4. 4.↵
    1. van Dijk K,
    2. Voets GM,
    3. Scharringa J,
    4. Voskuil S,
    5. Fluit AC,
    6. Rottier WC,
    7. Leverstein-Van Hall MA,
    8. Cohen Stuart JW
    . 2014. A disc diffusion assay for detection of class A, B and OXA-48 carbapenemases in Enterobacteriaceae using phenyl boronic acid, dipicolinic acid and temocillin. Clin Microbiol Infect 20: 345–9. doi:10.1111/1469-0691.12322.
    OpenUrlCrossRefPubMed
  5. 5.↵
    1. Dortet L,
    2. Agathine A,
    3. Naas T,
    4. Cuzon G,
    5. Poirel L,
    6. Nordmann P
    . 2015. Evaluation of the RAPIDEC CARBA NP, the Rapid CARB Screen and the Carba NP test for biochemical detection of carbapenemase-producing Enterobacteriaceae. J Antimicrob Chemother 70:3014–3022. doi:10.1093/jac/dkv213.
    OpenUrlCrossRefPubMed
  6. 6.↵
    1. Mirande C,
    2. Canard I,
    3. Buffet Croix Blanche S,
    4. Charrier JP,
    5. van Belkum A,
    6. Welker M,
    7. Chatellier S
    . 2015. Rapid detection of carbapenemase activity: benefits and weaknesses of MALDI-TOF MS. Eur J Clin Microbiol Infect Dis 34:2225–2234. doi:10.1007/s10096-015-2473-z.
    OpenUrlCrossRefPubMed
  7. 7.↵
    1. Pires J,
    2. Novais A,
    3. Peixe L
    . 2013. Blue-Carba, an easy biochemical test for detection of diverse carbapenemase producers directly from bacterial cultures. J Clin Microbiol 51:4281–4283. doi:10.1128/JCM.01634-13.
    OpenUrlFREE Full Text
  8. 8.↵
    1. Woodford N,
    2. Eastaway AT,
    3. Ford M,
    4. Leanord A,
    5. Keane C,
    6. Quayle RM,
    7. Steer JA,
    8. Zhang J,
    9. Livermore DM
    . 2010. Comparison of BD Phoenix, Vitek 2, and MicroScan automated systems for detection and inference of mechanisms responsible for carbapenem resistance in Enterobacteriaceae. J Clin Microbiol 48:2999–3002. doi:10.1128/JCM.00341-10.
    OpenUrlAbstract/FREE Full Text
  9. 9.↵
    1. Ote I,
    2. Bogaerts P,
    3. Denome L,
    4. Borlon C,
    5. Thunissen C,
    6. Glupczynski Y,
    7. Leclipteux T,
    8. Mertens P
    . 2015. Development of a novel immunochromatographic confirmatory test for the detection of OXA-48 carbapenemase in Enterobacteriaceae. Abstr 25th Eur Cong Clin Microbiol Infect Dis, 25 to 28 April 2015, Copenhagen, Denmark.
  10. 10.↵
    1. Dallenne C,
    2. Da Costa A,
    3. Decré D,
    4. Favier C,
    5. Arlet G
    . 2010. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 65:490–495. doi:10.1093/jac/dkp498.
    OpenUrlCrossRefPubMedWeb of Science
  11. 11.↵
    1. Potron A,
    2. Nordmann P,
    3. Lafeuille E,
    4. Al Maskari Z,
    5. Al Rashdi F,
    6. Poirel L
    . 2011. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 55:4896–4899. doi:10.1128/AAC.00481-11.
    OpenUrlAbstract/FREE Full Text
View Abstract
PreviousNext
Back to top
Download PDF
Citation Tools
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae
David W. Wareham, Rishita Shah, Jonathan W. Betts, Lynette M. Phee, Muhd Haziq F. Abdul Momin
Journal of Clinical Microbiology Jan 2016, 54 (2) 471-473; DOI: 10.1128/JCM.02900-15

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Print

Alerts
Sign In to Email Alerts with your Email Address
Email

Thank you for sharing this Journal of Clinical Microbiology article.

NOTE: We request your email address only to inform the recipient that it was you who recommended this article, and that it is not junk mail. We do not retain these email addresses.

Enter multiple addresses on separate lines or separate them with commas.
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae
(Your Name) has forwarded a page to you from Journal of Clinical Microbiology
(Your Name) thought you would be interested in this article in Journal of Clinical Microbiology.
Share
Evaluation of an Immunochromatographic Lateral Flow Assay (OXA-48 K-SeT) for Rapid Detection of OXA-48-Like Carbapenemases in Enterobacteriaceae
David W. Wareham, Rishita Shah, Jonathan W. Betts, Lynette M. Phee, Muhd Haziq F. Abdul Momin
Journal of Clinical Microbiology Jan 2016, 54 (2) 471-473; DOI: 10.1128/JCM.02900-15
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Top
  • Article
    • ABSTRACT
    • TEXT
    • ACKNOWLEDGMENTS
    • FOOTNOTES
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

Cited By...

About

  • About JCM
  • Editor in Chief
  • Board of Editors
  • Editor Conflicts of Interest
  • For Reviewers
  • For the Media
  • For Librarians
  • For Advertisers
  • Alerts
  • RSS
  • FAQ
  • Permissions
  • Journal Announcements

Authors

  • ASM Author Center
  • Submit a Manuscript
  • Article Types
  • Resources for Clinical Microbiologists
  • Ethics
  • Contact Us

Follow #JClinMicro

@ASMicrobiology

       

ASM Journals

ASM journals are the most prominent publications in the field, delivering up-to-date and authoritative coverage of both basic and clinical microbiology.

About ASM | Contact Us | Press Room

 

ASM is a member of

Scientific Society Publisher Alliance

Copyright © 2019 American Society for Microbiology | Privacy Policy | Website feedback

Print ISSN: 0095-1137; Online ISSN: 1098-660X